Alopecia areata and hair transplant

A transplant moves follicles; it does not stop the condition driving hair loss. Medical control and a clear diagnosis generally come before any discussion of surgery.

Alopecia areata can change location, expand or regrow unpredictably. Follicles taken from a donor area may later be affected, while further loss around transplanted hairs can create an uneven result. Surgery also uses a limited donor supply that cannot simply be replaced.

Some permanent-looking patches have another cause, such as scarring hair loss, traction or pattern hair loss. Those conditions require different planning. A dermatologist may inspect the scalp closely and occasionally recommend additional testing before naming the type of hair loss.

Start with a dermatologist who treats hair disorders. Record when each patch appeared, whether it is still changing, what treatments you have tried, and whether eyebrows, eyelashes, beard or nails are involved. Serial photographs can help show whether the condition is stable.

Discuss non-surgical options matched to the extent and location of loss. Depending on the clinical picture, options may include corticosteroids applied to or injected into affected skin, or medicines that alter immune signalling. Cosmetic fibres, hairpieces and scalp styling can provide coverage without using donor follicles.

Arrange prompt review if patches are spreading quickly, hair is shedding widely, or eyebrows and eyelashes are being lost. Pain, scaling, pustules, marked redness or shiny scar-like skin are additional reasons for assessment because they may point to inflammation, infection or scarring.

Before paying a deposit or scheduling surgery, seek an opinion from a dermatologist independent of the transplant provider. The review should address diagnosis, current activity, donor-area health and the possibility of future loss.

Ask what findings confirm alopecia areata, whether there is evidence of active loss, and what outcome is realistic without surgery. If transplantation is still being discussed, ask how the donor area was assessed, what would happen if new patches developed, and which medical treatments would continue.